Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National HealthCare Corporation (NHC) SEC filings page provides access to the company’s regulatory disclosures as a NYSE American issuer. NHC’s common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol NHC. Through its affiliates, the company operates skilled nursing facilities, assisted living and independent living communities, behavioral health hospitals, homecare agencies, and hospice agencies, along with Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third party post-acute operators.
In its Form 8-K current reports, NHC discloses material events such as quarterly and annual earnings releases, dividend declarations, and significant lease and governance matters. For example, the company files 8-Ks to furnish earnings press releases for periods ended March 31, June 30, September 30, and December 31, and to announce quarterly common dividends. These filings often reference non-GAAP financial measures and include or incorporate reconciliations to GAAP results.
NHC’s 8-K filings also describe corporate governance and executive changes, including the appointment of new directors, committee assignments, and planned retirements of senior officers, as well as role changes for executives. Additional 8-Ks address lease arrangements, such as disclosures about a master lease with National Health Investors, Inc., letters alleging non-monetary non-compliance, cure periods, renewal options, and the potential for a material adverse impact on NHC’s financial position and results of operations if certain lease rights were lost.
On this page, users can review NHC’s SEC reports as they are made available through EDGAR and use AI-powered summaries to understand the key points in lengthy filings. These tools can help clarify topics such as segment reporting for inpatient services and home care hospice services, dividend practices, lease terms and disputes, and board and executive leadership changes, without replacing the full text of the official documents.
National Healthcare Corp CEO Stephen Fowler Flatt reported several equity transactions involving company stock. He exercised options to acquire 5,000 shares of common stock on
As part of the same event, 3,585 shares of common stock were withheld by the company at a price of
Flatt Stephen Fowler reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp CEO Stephen Fowler Flatt was granted 3,090 shares of common stock on February 27, 2026, as a stock award with no cash paid per share. The grant consists of restricted shares subject to a three-year vesting schedule.
The award vests in three equal installments of 33 1/3% on January 1 of 2027, 2028, and 2029. The Form 4 also reports several option-to-purchase-common-stock positions, with post-transaction holdings of 6,147, 10,000, 18,000, and 20,000 option shares held directly.
National Healthcare Corp reported that SVP and CFO Brian F. Kidd acquired 1,507 shares of common stock on a grant or award basis at $0.00 per share. Following this grant, his directly held common stock totals 25,224 shares.
The footnote explains these are restricted shares that vest over three years, with 33 1/3% vesting on 1/1/2027, another 33 1/3% on 1/1/2028, and the final 33 1/3% on 1/1/2029. The filing also lists existing options to purchase common stock held directly.
National Healthcare Corp reported that Senior VP & General Counsel Josh A. McCreary acquired 1,458 shares of common stock on a restricted basis. These restricted shares vest over three years, in equal 33 1/3% installments on January 1 of 2027, 2028, and 2029. Following this grant, he directly holds 11,400 common shares, along with multiple option awards to purchase common stock reported as existing holdings.
FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.
National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr. received a grant of 1,342 shares of common stock on February 27, 2026. These are restricted shares granted at $0.00 per share, increasing his directly held common stock to 15,459.0547 shares after the award.
The restricted shares vest over three years, with 33 1/3% vesting on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029. The filing also reports option holdings to purchase common stock, with several option positions listed as directly owned holdings.
NATIONAL HEALTHCARE CORP director William A. Adams filed an initial statement of beneficial ownership on Form 3. This filing identifies him as a director of the company and establishes his reporting status for future insider transactions, but does not itself report any share purchases or sales.
National HealthCare Corporation reported strong 2025 results, with net operating revenues and grant income of
GAAP net income attributable to NHC rose to
In the fourth quarter, GAAP net income attributable to NHC was
National HealthCare Corporation reports on its 2025 business, highlighting a broad post‑acute and senior care platform across 9 states, focused on skilled nursing, assisted living, independent living, homecare, hospice and behavioral health hospitals.
As of December 31, 2025, the company operated 80 skilled nursing facilities with 10,329 licensed beds, 26 assisted living facilities with 1,413 units, 9 independent living facilities with 777 retirement apartments, 3 behavioral health hospitals, plus 34 homecare and 33 hospice agencies. Owned and leased skilled nursing facilities posted an 89.7% overall census in 2025. About 96.8% of 2025 net operating revenues came from healthcare services, with payer mix of 31% Medicare, 30% Medicaid, 12% managed care and 27% private pay and other.
NHC emphasizes quality, with 62.5% of its 80 skilled nursing centers rated 4 or 5 stars by CMS and an average rating of 3.83 versus the industry’s 2.95. It expanded via the August 2024 acquisition of White Oak Management’s portfolio of 15 skilled nursing, 2 assisted living and 4 independent living facilities plus a pharmacy.
The company details exposure to reimbursement and regulatory shifts, including CMS payment updates across skilled nursing, home health and hospice, supplemental Medicaid payments, and a significant lease dispute with major landlord National Health Investors that could affect future occupancy costs and facility control. NHC also outlines labor shortages, potential staffing mandates, climate and disaster risks, extensive healthcare and privacy regulation, and rising public‑company compliance demands.
NATIONAL HEALTHCARE CORP reported that Senior VP & General Counsel Josh A. McCreary received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026, at an exercise price of $0.00 per share.
The options were granted under the 2020 Omnibus Equity Incentive Plan and will vest in three equal parts: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. The grant is described as exempt from Section 16(b) under Rule 16b-3(d).
National Healthcare Corp senior executive receives stock option grant. Sr. VP Patient Services Vicki L. Dodson was granted options to purchase 14,000 shares of National Healthcare Corp common stock on February 23, 2026, at an exercise price of $0.00 per share under the 2020 Omnibus Equity Incentive Plan.
According to the grant’s terms, these stock options vest in three equal installments: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. Following the grant, she directly holds multiple option positions and 10,289.5455 shares of common stock in her name.